Rich J. Tajak, M.B.A.
Chief Financial Officer
Mr. Tajak joined NantKwest as its Chief Financial Officer in 2016. Since 2011, Mr. Tajak has also been serving as Chief Financial Officer for Nant Works and subsequently, Chief Financial Officer and Chief Operating Officer for Nant Pharma. Mr. Tajak brings more than 30 years of pharmaceutical industry financial experience. From 2008, he served as Chief Financial Officer for APP Pharmaceuticals, Inc., a $1 billion publicly-traded generic pharmaceutical company. Prior to that, he was Senior Vice President, Finance for the $1.5 billion North American division of Astellas Pharmaceuticals, Inc. Earlier in his earlier career he served at Fujisawa Healthcare/USA and Lyphomed, Inc., where he had increasing levels of responsibility in the areas of accounting, finance, SEC reporting, audit, tax and corporate operations. Mr. Tajak holds a Bachelor’s degree in Finance and an MBA from the University of Notre Dame, and is a Certified Public Accountant.